Exact Mass: 289.0409
Exact Mass Matches: 289.0409
Found 233 metabolites which its exact mass value is equals to given mass value 289.0409,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Succinyl-2-amino-6-ketopimelate
N-Succinyl-2-amino-6-ketopimelate is an intermediate in lysine biosynthesis. It is the fourth to last step in the synthesis of lysine and is converted. from tetrahydrodipicolinate via the enzyme tetrahydrodipicolinate N-succinyltransferase (EC 2.3.1.117). It is then converted to N-succinyl-L,L-2,6-diaminopimelate via the enzyme Succinyldiaminopimelate transferase (EC 2.6.1.17). N-Succinyl-2-amino-6-ketopimelate is an intermediate in lysine biosynthesis. It is the fourth to last step in the synthesis of lysine and is converted
Quinethazone
Quinethazone is only found in individuals that have used or taken this drug. It is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.As a diuretic, quinethazone inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like quinethazone also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of quinethazone is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)methanesulfonamide
2-[(6-Aminopurin-9-yl)methoxy]ethyl dihydrogen phosphate
Adrafinil
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
(4-Methoxyphenyl)-morpholin-4-yl-sulfanyl-sulfanylidene-$l^{5}-phosphane
p-coumaroyltriacetate
P-coumaroyltriacetate belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. P-coumaroyltriacetate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). P-coumaroyltriacetate can be found in a number of food items such as common thyme, cowpea, swiss chard, and groundcherry, which makes P-coumaroyltriacetate a potential biomarker for the consumption of these food products.
ADRAFINIL
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidine-3-carboxylic acid
3-Benzo[b]furan-2-yl-2-(tert-butylsulfonyl)acrylonitrile
2-(1,3-Dioxo-2,3-dihydro-1H-inden-2-yliden)-2-[(3-pyridylmethyl)amino]acetonitrile
N-[2,5-Dioxo-6-(hydroxymethyl)-7-oxabicyclo[4.1.0]hepta-3-ene-3-yl]salicylamide
2-[2,6-Bis(methylsulfinyl)-4-hydroxyphenyl]diazenecarboxamide
(-)-8S-3-bromo-5-hydroxy-4-methoxyphenylalanine|2-amino-3-(3-bromo-5-hydroxy-4-methoxyphenyl)propanoic acid
Isocarbophos
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
2-OXAZOLIDINONE, 3-(3-FLUOROPHENYL)-5-[[(METHYLSULFONYL)OXY]METHYL]-, (5R)-
2-AMINO-4-[2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLAMINO]-1,3,5-TRIAZINE 98
TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE
5-chloro-7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidine
3,5-DINITROBENZOYL-N-(N-PROPYL)AMINE HYDROCHLORIDE
Improsulfan
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
4-(6-CHLOROPYRIDINE-3-CARBONYL)BENZOIC ACID ETHYL ESTER
4-{[2-FLUORO-5-(METHYLSULFONYL)PHENYL]AMINO}-4-OXOBUTANOICACID
3-AMINO-3-(3-BROMO-4-HYDROXY-5-METHOXY-PHENYL)-PROPIONIC ACID
3-AMINO-3-(5-BROMO-3-METHOXY-2-HYDROXY-PHENYL)-PROPIONIC ACID
N-[(4-methoxyphenyl)methylidene]-4-methylbenzenesulfonamide
N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide
1-(3-CHLORO-BENZYL)-PIPERIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
proguanil hydrochloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007004 - Hypoglycemic Agents > D001645 - Biguanides D009676 - Noxae > D000963 - Antimetabolites
2-(5-CHLORO-THIOPHEN-2-YL)-QUINOLINE-4-CARBOXYLIC ACID
4-(methylthio)-2-[(phenylsulfonyl)amino]butanoic acid
Methyl 3-(5-fluoro-2-(trifluoromethyl)-1H-indol-3-yl)propanoate
Benzamide,N-[2-(chloroacetyl)phenyl]-4-hydroxy- (9CI)
2-(4-bromo-2,5-dimethoxyphenyl)-2-methoxyethanamine
PYRIDINE-4-CARBOXYLIC ACID PENTAFLUOROPHENYL ESTER
2-AMINO-5-CBZ-4,5,6,7-TETRAHYDRO-1,3-THIAZOLO[5,4-C]PYRIDINE
5-AMINO-N-(2,3-DIHYDROXY-1-PROPYL)-ISOPHTHALAMIDE HYDROCHLORIDE
3-(4-FLUOROPHENYL)-5-(FURAN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE
2-Ethylsulfonylimidazo[1,2-a]pyridine-3-sulfonamide
Tizanidine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002491 - Central Nervous System Agents > D000700 - Analgesics Tizanidine hydrochloride is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Target: α2-adrenergic receptor Tizanidine is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia. Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam. Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa. Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5\% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment.
(S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
Satranidazole
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
methyl 2-amino-7-methoxy-4,5-dihydrobenzo[e][1]benzothiole-1-carboxylate
6-(CHLOROMETHYL)-2-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PYRIMIDIN-4-OL
(3-Chloro-4-fluorophenyl)[4-fluoro-4-(hydroxymethyl)-1-piperidinyl]methanone
N-(4-Chloro-3-cyano-6-ethoxy-7-quinolinyl)acetamide
1H-Benz[g]indole-3-carboxaldehyde,2-(4-fluorophenyl)-(9CI)
4-chloro-2-(4-fluorophenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
Nicoclonate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid
[3-[(2-chloro-4-methylphenyl)carbamoyl]phenyl]boronic acid
4-(6-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
4-(4-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
2-(4-amino-3-methoxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
(4-((3-CHLORO-4-METHYLPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
(2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4,5-DIYL)DIMETHANOL
methyl 4-chloro-2-(trifluoromethyl)quinoline-6-carboxylate
3-[(2-HYDROXYETHYL)THIO]-6-NITRO-2,3-DIHYDRO-1H-1LAMBDA6-BENZO[B]THIOPHENE-1,1-DIONE
1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone
5-Bromo-1,2-dicarboxylic acid-1H-Pyrrole 1-(1,1-dimethylethyl) ester
(2-Chloro-pyridin-3-yl)-(4-MethylaMino-piperidin-1-yl)-Methanone hydrochloride
METHYL 4-CHLORO-6-TRIFLUOROMETHYL-QUINOLINE-2-CARBOXYLATE
(3-(4-CHLOROBENZO[D]THIAZOL-2-YL)PHENYL)BORONIC ACID
dicarbonyl(pentamethylcyclopentadienyl)molybdenum dimer
Methyl [1-(1,3-benzothiazol-2-yl)-5-hydroxy-1H-pyrazol-3-yl]acetate
(3-((3-CHLORO-2-METHYLPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
Methyl 1-(2-nitro-4-(trifluoromethyl)phenyl)cyclopropanecarboxylate
Benzofuro(3,2-d)pyrimidin-4(3H)-one, 8-chloro-2-((2S)-2-pyrrolidinyl)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
1-(5-Chloroindol-3-YL)-3-hydroxy-3-(2H-tetrazol-5-YL)-propenone
(4-Methoxyphenyl)(morpholino)phosphinodithioic acid
(1R)-6-Chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
5-Hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one
N-(4-methylphenyl)-2-(3-oxo-5,6-dihydroimidazo[2,1-b]thiazol-2-yl)acetamide
2-[[Anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide
3-[(1-Methyl-5-tetrazolyl)thio]-1-phenylpyrrolidine-2,5-dione
2-[(1-Oxo-3-phenylpropyl)amino]-3-thiophenecarboxylic acid methyl ester
6-Amino-2-methoxy-5-(phenylsulfonyl)nicotinonitrile
Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-(hydroxymethyl)phenyl)-
(2S)-5-[[amino-(sulfonatoamino)phosphoryl]amino]-2-azaniumylpentanoate
2-Hydroxy-5-[2-(4-nitrophenyl)hydrazinyl]benzoic acid
6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
5-Chloropyridin-3-yl benzo[b]thiophene-2-carboxylate
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
2-(4-Amino-6-hydroxy-pyrimidin-2-ylsulfanyl)-1-(3,4-dimethyl-phenyl)-ethanone
2-Chloro-5-[(2E)-2-(1-pyridin-2-ylethylidene)hydrazinyl]benzoic acid
2-[(2,5-Dimethoxyphenyl)sulfonyl-methylamino]acetic acid
N-(Carboxymethyl)-N,N,N-tris(carboxylatomethyl)ethylenediamine
2-[(4-Methyl-2-pyrimidinyl)thio]-1-(3-nitrophenyl)ethanone
2-[[5-(3-Methylphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]acetic acid
N-{[2-(4-chlorophenyl)acetyl]oxy}pyridine-2-carboximidamide
2-[2-(3,5-Dimethyl-1-pyrazolyl)ethyl]-4-thiophen-2-ylthiazole
2-(Methanesulfonamido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
N-(5-pyridin-2-ylthiophen-2-yl)morpholine-4-carboxamide
1-benzyl-3-[(E)-1-thiophen-2-ylethylideneamino]thiourea
Ethyl 5-amino-1-thieno[2,3-d]pyrimidin-4-ylpyrazole-4-carboxylate
6-Chloro-3-[2-(2-furanyl)-2-oxoethyl]-1,4-benzoxazin-2-one
(2R)-2-amino-3-[[5-(2-hydroperoxyethyl)-2,3-dihydroxyphenyl]thio]propanoic acid
2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
3-(alpha-Hydroxy-4-nitrobenzyl)-2,5-dihydroxy-2,4,6-cycloheptatrien-1-one
Rel-(1R,5R,11R)-3-(4-nitrophenyl)-hydroxymethyl-6,7-dioxabicyclo(3.2.2)nona-3,8-dien-2-one
QUINETHAZONE
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
(2S)-2-(3-carboxypropanamido)-6-Oxoheptanedioic acid
N-(6-Oxo-6H-benzo(c)chromen-2-yl)methanesulfonamide
fumisoquin C(1-)
A monocarboxylic acid anion that is the conjugate base of fumisoquin C, obtained from the deprotonation of the carboxy group. Major microspecies at pH 7.3.
